Day | 0 | 1 | 2 | 3 | 7 | 14 | 21 | 28 | 35 | 42 | 49 | 56 | 63 | Any other day1 | Delivery | 4-6 weeks post-partum | EPI clinics | 1 year post-partum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
History (symptoms) | X | |||||||||||||||||
Informed consent | X | |||||||||||||||||
Examination (clinical) | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
Foetal viability | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
Blood Pressure | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
Temperature | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
Blood film | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
Filter paper PCR | X | X | X | X | X | X | X | X | X | X | X | X 2 | ||||||
Adverse events | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||
Concomitant medications | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
Hb | X | X | X | X | X | X | X | |||||||||||
Haematology | X | X | X | X | X | X | ||||||||||||
Treatment | X | X | X | |||||||||||||||
Blood sample for PK | X | |||||||||||||||||
Pop PK | 3 samples/woman according to a predefined schedule (120 women in 3 sites each) | |||||||||||||||||
In vitro test | X | and time of recurrent infection | ||||||||||||||||
Biochemistry | X | X | X | X3 | X4 | |||||||||||||
Placenta sample | X | |||||||||||||||||
New born assessment | X | X | ||||||||||||||||
Infant assessment | X | X |